NCT05592886View on ClinicalTrials.gov

A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers

NARecruitingINTERVENTIONAL
Enrollment

649

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

December 15, 2027

Study Completion Date

December 31, 2027

Conditions
Colorectal NeoplasmsColorectal AdenomaColorectal CancerAdvanced Adenoma
Interventions
OTHER

SMT04 formula

The SMT04 formula is a synbiotic containing probiotics and prebiotics

OTHER

Active placebo

The active placebo is 2 mg Vitamin C with an inert substance made of starch filler. The flavor, coloring and appearance are unidentifiable to the study product.

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Inner Mongolia People's Hospital, Hohhot

RECRUITING

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
collaborator

Inner Mongolia People's Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER